OrbiMed
177 portfolio companies · 137 on the map · $9.6B raised · 86 cities
Portfolio map
137 OrbiMed portfolio companies on the map.
Portfolio companies
Intellia Therapeutics
Cambridge
Intellia Therapeutics is a genome editing company that develops curative gene-editing treatments.
Biotechnology Research$1.7BEst. 2014
Harmony Biosciences
Plymouth Meeting
Harmony Biosciences is a pharmaceutical company that develops and commercializes novel therapies for rare neurological disorders.
Pharmaceutical Manufacturing$1.7BEst. 2017
Janux Therapeutics
San Diego
Janux Therapeutics develops immunotherapies that generates immune responses to prevent tumors and not affecting a patient’s healthy tissue.
Biotechnology Research$898.9MEst. 2017
Arcutis Biotherapeutics
Westlake Village
Arcutis Biotherapeutics is a clinical-stage biopharmaceutical company focused on developing medical dermatology for unmet needs.
Biotechnology Research$833.5MEst. 2016
Mineralys Therapeutics
Radnor
Mineralys Therapeutics is a clinical-stage biopharmaceutical company committed to developing therapy for the treatment of hypertension.
Biotechnology Research$740.5MEst. 2020Hiring fast
Invivyd
New Haven
Invivyd develops antibodies to transcend the limitations of the human immune system and fight against viral infections.
Biotechnology Research$678.5MEst. 2020
Avalo Therapeutics
Chesterbrook
Avalo Therapeutics is a clinical-stage biopharmaceutical company.
Biotechnology$606.5MEst. 2011
Aspen Neuroscience
La Jolla
Aspen Neuroscience is a biotechnology company that specializes in personalized cell therapies and autologous regenerative medicine.
Biotechnology Research$387MEst. 2018
Keros Therapeutics
Lexington
Keros is a clinical-stage biopharmaceutical company focusing on the discovery, development, and commercialization of novel treatments.
Biotechnology Research$379.5MEst. 2016
Alentis Therapeutics
Allschwil
ALENTIS Therapeutics is a Swiss-French biotech company developing novel therapeutics in advanced liver disease and cancer.
Pharmaceutical Manufacturing$365.4MEst. 2019
DELFI Diagnostics
Palo Alto
Delfi Diagnostics detects cancer early, when it is most curable, using high precision non-invasive blood tests.
Medical and Diagnostic Laboratories$364.8MEst. 2019
Mirador Therapeutics
San Diego
Mirador Therapeutics develops precision medicines for immune-mediated diseases.
Biotechnology Research$250MEst. 2024
Cerapedics
Westminster
CeraPedics is a medical device company that focuses on developing and commercializing novel osteobiologic products.
Biotechnology Research$205.7MEst. 2001
Trisalus Life Sciences
Westminster
TriSalus Life Sciences develops novel infusion systems for the interventional radiology market.
Biotechnology Research$193.6MEst. 2009
Cytek Biosciences
Fremont
Cytek Biosciences is a manufacturer and supplier of flow cytometry products and services.
Biotechnology Research$144.3MEst. 1992
Noctrix Health
Pleasanton
Noctrix Health is an early-stage medical device company that focuses on developing a revolutionary therapy for a chronic illness.
Medical Equipment Manufacturing$90.5MEst. 2018
Adimab
Lebanon
Adimab is an antibody discovery and optimization platform, developing full-length human Immunoglobulin Gs.
Biotechnology Research$45.5MEst. 2007Koya Medical
Dallas
Koya Medical is a transformative healthcare company developing breakthrough treatments for lymphedema and venous diseases.
Medical Equipment ManufacturingSeries CEst. 2018
Verastem Oncology
Needham
Verastem is a biopharmaceutical company developing new medicines to improve the lives of patients with RAS/MAPK pathway-driven cancers.
Biotechnology ResearchPublicEst. 2010- S
Synthorx
La Jolla
Synthorx is a biotechnology company using synthetic biology to synthesize solutions.
Biotechnology ResearchSeries CEst. 2014 
LEXICON PHARMACEUTICALS
The Woodlands
Lexicon Pharmaceuticals is a biopharmaceutical company that discovers and develops precise medicines for human disease.
Pharmaceutical ManufacturingPublicEst. 1995
NeuroPace
Mountain View
NeuroPace develops and markets implantable devices for the treatment of neurological disorders.
Medical Equipment ManufacturingPublicEst. 1999- TT
Targanta Therapeutics
Cambridge
Targanta Therapeutics is a biopharma Company
Pharmaceutical ManufacturingSeries CEst. 2005 enGene
Vancouver
Vancouver-based.
Post IPO EquityOwlet Baby Care
Lehi
Lehi-based.
Post IPO EquityPerfuse Therapeutics
South San Francisco
South San Francisco-based.
Series ASidewinder Therapeutics
San Diego
San Diego-based.
Series BTerremoto Biosciences
San Francisco
San Francisco-based.
Series CBlossomHill Therapeutics
San Diego
San Diego-based.
Series BTerns Pharmaceuticals
Foster City
Foster City-based.
Series CAvenzo Therapeutics
San Diego
San Diego-based.
Series BRayzeBio
San Diego
San Diego-based.
Series CvVardis
Baar
Baar-based.
Venture RoundBiobeat
Boca Raton
Boca Raton-based.
Series BFore Biotherapeutics
Philadelphia
Philadelphia-based.
Series DSpectronRx
Indianapolis
Indianapolis-based.
Private Equity RoundCompass Therapeutics
Boston
Boston-based.
Post IPO EquityQ32 Bio
Cambridge
Cambridge-based.
Post IPO EquityMinervax
Hellerup
Hellerup-based.
Venture RoundKapiva
Bengaluru
Bengaluru-based.
Series CReCode Therapeutics
Dallas
Dallas-based.
Series Bargenx
Boston
Boston-based.
Series BApollomics
Foster City
Foster City-based.
Series BPee Safe
Gurgaon
Gurgaon-based.
Series CRepare Therapeutics
Saint Laurent
Saint Laurent-based.
Series BZai Lab
Shanghai
Shanghai-based.
Series CEdgewise Therapeutics
Boulder
Boulder-based.
Post IPO EquityLeal Therapeutics
Worcester
Worcester-based.
Series AInsmed
Bridgewater
Bridgewater-based.
Post IPO DebtProLynx
San Francisco
San Francisco-based.
Series AStratus Therapeutics
Cambridge
Cambridge-based.
Series ABinx Health
Boston
Boston-based.
Series EQuantX Biosciences
Princeton
Princeton-based.
Series AMyriad Genetics
Salt Lake City
Salt Lake City-based.
Post IPO DebtCongruence Therapeutics
Montréal
Montréal-based.
Venture RoundSionna Therapeutics
Natick
Natick-based.
Series CAscendis Pharma
Palo Alto
Palo Alto-based.
Series DIovance Biotherapeutics
New York
New York-based.
Post IPO EquityAvita Medical
Valencia
Valencia-based.
Post IPO DebtETHRIS
Planegg
Planegg-based.
Series AAdela
Foster City
Foster City-based.
Series AHelicore Biopharma
San Mateo
San Mateo-based.
Series AAlpheus Medical
Oakdale
Oakdale-based.
Series BVanqua Bio
Chicago
Chicago-based.
Series BYarrow
New York
New York-based.
Venture RoundValneva
Saint-herblain
Saint-herblain-based.
Post IPO DebtACELYRIN
Los Angeles
Los Angeles-based.
Series CEmendoBio, Inc.
New York
New York-based.
Series BC4 Therapeutics
Cambridge
Cambridge-based.
Post IPO Equitysikka.ai
San Jose
San Jose-based.
Series CLifeCell International
Chennai
Chennai-based.
Venture RoundPionyr Immunotherapeutics
South San Francisco
South San Francisco-based.
Series BFate Therapeutics
La Jolla
La Jolla-based.
Post IPO EquityAdaptive Biotechnologies
Seattle
Seattle-based.
Post IPO DebtNetmeds
Chennai
Chennai-based.
Series AScout Bio
Philadelphia
Philadelphia-based.
Series BPinnacle Medicines
Doylestown
Doylestown-based.
Series AInvitae
San Francisco
San Francisco-based.
Series FTheseus Pharmaceuticals
New York
New York-based.
Series BImmPACT Bio
Camarillo
Camarillo-based.
Series BDIH Technology
Volketswil
Volketswil-based.
Post IPO EquityCullinan Therapeutics
Cambridge
Cambridge-based.
Post IPO EquityPromentis Pharmaceuticals
Milwaukee
Milwaukee-based.
Series CMabPlex International
Fremont
Fremont-based.
Series BSuraksha Diagnostics
Kolkata
Kolkata-based.
Venture Round89bio
San Francisco
San Francisco-based.
Series ABIOMx
Ness Ziona
Ness Ziona-based.
Post IPO EquityVIVUS
Mountain View
Mountain View-based.
Post IPO EquityCyrus Biotechnology
Seattle
Seattle-based.
Series BPassage Bio
Philadelphia
Philadelphia-based.
Series BHarvest Integrated Research Organization
Excelsior
Excelsior-based.
Series ARedHill Biopharma
Tel Aviv
Tel Aviv-based.
Post IPO EquityFusion Pharmaceuticals
Hamilton
Hamilton-based.
Series BCorvus Pharmaceuticals
Burlingame
Burlingame-based.
Post IPO EquityKerala Institute of Medical Sciences
Thiruvananthapuram
Thiruvananthapuram-based.
Private Equity RoundAlpine Immune Sciences
Seattle
Seattle-based.
Post IPO EquityAvitide
Lebanon
Lebanon-based.
Series EArcatron Mobility
Pune
Pune-based.
Venture RoundTELA Bio
Malvern
Malvern-based.
Venture RoundSublimity Therapeutics
Dublin
Dublin-based.
Venture RoundSierra Oncology
San Mateo
San Mateo-based.
Series DscPharmaceuticals
Lexington
Lexington-based.
Series BMobileODT
Tel Aviv
Tel Aviv-based.
Series CViewRay
Oakwood
Oakwood-based.
Post IPO EquityCorteria Pharmaceuticals
Paris
Paris-based.
Series ATricida
Menlo Park
Menlo Park-based.
Post IPO EquityAeglea BioTherapeutics
Austin
Austin-based.
Series BChinook Therapeutics
Vancouver
Vancouver-based.
Post IPO EquityAttenua
Mountain View
Mountain View-based.
Series APandion Therapeutics
Cambridge
Cambridge-based.
Series BChemoCentryx
San Carlos
San Carlos-based.
Series DOrnim Medical
Lod
Lod-based.
Series CNeurogastrx
Woburn
Woburn-based.
Series BGelesis
Boston
Boston-based.
Series BNabriva Therapeutics
Vienna
Vienna-based.
Series BAthenex
Buffalo
Buffalo-based.
Post IPO EquitySientra
Franklin
Franklin-based.
Series CAnthera Pharmaceuticals
Hayward
Hayward-based.
Post IPO EquityTurning Point Therapeutics
San Diego
San Diego-based.
Private Equity RoundMagenta Therapeutics
Cambridge
Cambridge-based.
Post IPO EquityVivimed Labs
Hyderabad
Hyderabad-based.
Post IPO EquityMedigus
Omez
Omez-based.
Post IPO EquityForteBio
Menlo Park
Menlo Park-based.
Series CEddingpharm (Cayman)
Kowloon City
Kowloon City-based.
Series BAmarin
Ballsbridge
Ballsbridge-based.
Post IPO EquityCerimon Pharmaceuticals
South San Francisco
South San Francisco-based.
Series AManipal Acunova
Bangalore
Bangalore-based.
Venture RoundReceptos
San Diego
San Diego-based.
Venture RoundMID Labs
San Leandro
San Leandro-based.
Venture RoundShasun Pharma
Chennai
Chennai-based.
Private Equity RoundAmnis Corporation
Seattle
Seattle-based.
Series CRejuvenon
The Woodlands
The Woodlands-based.
Series BMethylGene
Montréal
Montréal-based.
Venture RoundAvalon Pharmaceuticals
Germantown
Germantown-based.
Series B
Principia Biopharma
South San Francisco
Sanofi is a global biopharma company focused on prescription drugs, vaccines, and treatments for chronic, rare, and infectious diseases.
BiotechnologyPublicEst. 2008Hiring fast
SI-BONE
Santa Clara
SI-BONE advances the diagnostic understanding of lower back pain and minimally invasive surgery for the sacroiliac joint.
Medical DevicePublicEst. 2008
Avanir Pharmaceuticals
Aliso Viejo
Otsuka Pharmaceuticals is a pharmaceutical company that operates throughout the globe.
Pharmaceutical ManufacturingPublicEst. 1988
More portfolio companies
38 more OrbiMed investments we track beyond the map — 177 tracked in total.
Caris Life SciencesIrving · Debt Financing
BioAge LabsRichmond · Series D
Apogee TherapeuticsSan Francisco · Series B
Nautilus BiotechnologySan Carlos · Post-IPO Equity
Carrot FertilityMenlo Park · Series C
Nuvation BioNew York · Post-IPO Equity
TigerConnectSanta Monica · Series C
Crossover HealthSan Clemente · Series D
NateraSan Carlos · Series F
CHARM TherapeuticsLondon · Series B
Treeline BiosciencesWatertown · Series A
Tyra BiosciencesCarlsbad · Post-IPO Equity
Verdiva BioLondon · Series A
Averna TherapeuticsBoston · Series A
TandemAIShanghai · Series A
Stairway MedicalPudong · Venture
EvozyneChicago · Series B
Evox TherapeuticsOxford · Series C
Health CatalystSalt Lake City · Debt Financing
Prelude TherapeuticsWilmington · Series C
EDDA TechnologyPrinceton · Private Equity
Clover BiopharmaceuticalsChengdu · Series C
Magenta MedicalKadima · Venture
NucleixRehovot · Venture
Inspire Medical SystemsMaple Grove · Series F
TransMedicsAndover · Post-IPO Debt
Aer TherapeuticsRaleigh · Series A
Shattuck LabsAustin · Post-IPO Equity
AlectorSan Francisco · Series E
Ikena OncologyBoston · Series B
AffimedHeidelberg · Series E
Acutus MedicalCarlsbad · Debt Financing
Aduro BioTechBerkeley · Series D
ImaraCambridge · Series B
ArsanisVienna · Series D
Practice FusionSan Francisco · Series D
Roka BioscienceWarren · Series D
Cerexa Inc.New York · Series A